Trial Profile
Phase I Trial of ABI-007 (Abraxane) Plus Cisplatin Plus 5-Fluorouracil (APF) as Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in Patients With Locally Advanced Squamous Cell Cancers of the Head and Neck (HNSCC)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Jun 2016
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary) ; Carboplatin; Cisplatin; Fluorouracil
- Indications Head and neck cancer
- Focus Adverse reactions
- 09 Jul 2015 Planned End Date changed from 1 Mar 2015 to 1 Sep 2015 as reported by ClinicalTrials.gov record.
- 09 Jul 2015 Planned primary completion date changed from 1 Dec 2014 to 1 Sep 2015 as reported by ClinicalTrials.gov record.
- 03 Jul 2014 Planned End Date changed from 1 Mar 2013 to 1 Mar 2015 as reported by ClinicalTrials.gov record.